Talo, Marasiya .

HRN: 03-91-05  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/20/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/20/2022
11/27/2022
IVTT
500mg
Q8
Pus Cells On Stool With Amoeba
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: